Results 251 to 260 of about 8,750,628 (402)

Finding More in Less: Precision Medicine for Pancreatic Cancer Using Residual Cytology Samples

open access: yesCytopathology, EarlyView.
The study evaluates the use of residual liquid‐based cytology (LBC) samples from pancreatic ductal adenocarcinoma (PDAC) for molecular analysis. It shows that LBC samples preserve nucleic acid quality and remain suitable for next‐generation sequencing (NGS) and MSI testing even after prolonged storage, underscoring their value when other samples are ...
Raquel Antón‐Peñalver   +17 more
wiley   +1 more source

Introduction: Future Research Directions in the Epidemiology of Human Papillomavirus and Cancer [PDF]

open access: bronze, 2003
F. X. Bosch   +2 more
openalex   +1 more source

HPV42 – a human papillomavirus classified as a low‐risk type with oncogenic potential

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Human papillomavirus (HPV) type 42 is a rare HPV type currently classified as “low‐risk” and belongs to the alpha genus. It has primarily been detected in benign vulvar papillomas and is predominantly associated with benign lesions such as anogenital warts.
Sven Niklas Burmann   +7 more
wiley   +1 more source

Impact of Wuchereria bancrofti Infection on Cervical Mucosal Immunity and Human Papillomavirus Prevalence in Women from Lindi and Mbeya Regions, Tanzania

open access: green
Mosoba, Maureen   +20 more
openalex   +1 more source

Aural plaques: Considerations on autohaemotherapy treatment in four Mangalarga Marchador crossbred horses

open access: yesEquine Veterinary Education, EarlyView.
Summary The occurrence of Aural Plaques (AP) in horses, attributed to infection with Equus caballus Papillomavirus (EcPV), has become increasingly prevalent in equine breeding populations. Major challenges in managing this condition include genetic susceptibility to the virus, significant variability in individual immune responses among horses and the ...
E. Bastianetto   +6 more
wiley   +1 more source

Controlled trial of cervical cancer screening frequency among human-papillomavirus-vaccinated women. [PDF]

open access: yesInt J Cancer
What's new? Since the introduction of the human papillomavirus (HPV) vaccine in 2006, vaccine‐type infections have declined markedly. As nonvaccine HPV types generally carry lower oncogenic potential, this shift warrants reevaluation of cervical screening regimens.
Ortega Llobet M   +10 more
europepmc   +2 more sources

Human Papillomavirus Vaccination Status and Its Predictors Among Medical Students

open access: diamond
Özgür Önal   +4 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy